DIAMEDICA THERAPEUTICS INC COMMON SHARES (DMCAF) SEC filings
DMCAF SEC filings moved a median of +1.74% by the close. DMCAF SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the DMCAF overview →
56 measured DMCAF SEC filing events.
Where these DMCAF SEC filings landedvs 54 measured DMCAF SEC filing reactions
| Middle 50% of DMCAF SEC filing reactions | -3.09% to +4.29% |
|---|---|
| Median reaction (to close) | +1.74% |
| Measured reactions | 54 |
Point-in-time · zero look-ahead
Half of the 54 DMCAF SEC filing events with a measured close landed between -3.09% and +4.29%; 57% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form S-8 DiaMedica Therapeutics | SEC filing · Form S-8 | +0.15% | +3.00% | |
| Form 8-K DiaMedica Therapeutics For: May 20 | SEC filing · Form 8-K | +0.00% | +2.43% | |
| Form 10-Q DiaMedica Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.71% | +1.40% | |
| Form 8-K DiaMedica Therapeutics For: May 06 | SEC filing · Form 8-K | -1.71% | +1.40% | |
| Form ARS DiaMedica Therapeutics For: Dec 31 | SEC filing · Form ARS | +1.82% | +3.35% | |
| Form DEF 14A DiaMedica Therapeutics For: May 20 | SEC filing · Form DEF | +1.82% | +3.35% | |
| Form DEFA14A DiaMedica Therapeutics | SEC filing · Form DEFA14A | +1.82% | +3.35% | |
| Form 8-K DiaMedica Therapeutics For: Mar 30 | SEC filing · Form 8-K | -3.36% | -5.18% | |
| Form 10-K DiaMedica Therapeutics For: Dec 31 | SEC filing · Form 10-K | -3.36% | -5.18% | |
| Form 8-K DiaMedica Therapeutics For: Jan 05 | SEC filing · Form 8-K | +0.00% | +6.75% | |
| Form 8-K DiaMedica Therapeutics For: Dec 18 | SEC filing · Form 8-K | -1.18% | -1.89% | |
| Form 10-Q DiaMedica Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.95% | — | |
| Form 8-K DiaMedica Therapeutics For: Nov 12 | SEC filing · Form 8-K | +0.95% | — | |
| Form EFFECT DiaMedica Therapeutics | SEC filing · Form EFFECT | +0.66% | -0.33% | |
| Form 10-Q DiaMedica Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +2.86% | +22.45% | |
| Form 8-K DiaMedica Therapeutics For: Aug 12 | SEC filing · Form 8-K | +2.86% | +22.45% | |
| Form S-3 DiaMedica Therapeutics | SEC filing · Form S-3 | +2.86% | +22.45% | |
| Form EFFECT DiaMedica Therapeutics | SEC filing · Form EFFECT | -3.21% | -1.93% | |
| Form 8-K DiaMedica Therapeutics For: Aug 04 | SEC filing · Form 8-K | -0.64% | +0.00% | |
| Form S-3 DiaMedica Therapeutics | SEC filing · Form S-3 | -2.04% | -0.96% | |
| Form D DiaMedica Therapeutics | SEC filing · Form D | -0.10% | +2.85% | |
| Form 8-K DiaMedica Therapeutics For: Jul 21 | SEC filing · Form 8-K | +10.71% | +8.10% | |
| Form 8-K DiaMedica Therapeutics For: Jul 17 | SEC filing · Form 8-K | -5.20% | +2.08% | |
| Form 8-K DiaMedica Therapeutics For: May 15 | SEC filing · Form 8-K | -2.16% | +6.60% | |
| Form 10-Q DiaMedica Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +2.56% | +2.30% | |
| Form 8-K DiaMedica Therapeutics For: May 13 | SEC filing · Form 8-K | +2.56% | +2.30% | |
| Form ARS DiaMedica Therapeutics For: Dec 31 | SEC filing · Form ARS | -1.41% | -7.51% | |
| Form DEF 14A DiaMedica Therapeutics For: May 15 | SEC filing · Form DEF | -1.41% | -7.51% | |
| Form DEFA14A DiaMedica Therapeutics | SEC filing · Form DEFA14A | -1.41% | -7.51% | |
| Form 10-K DiaMedica Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.00% | -13.17% | |
| Form 8-K DiaMedica Therapeutics For: Mar 17 | SEC filing · Form 8-K | +0.00% | -13.17% | |
| Form 8-K DiaMedica Therapeutics For: Feb 28 | SEC filing · Form 8-K | +0.00% | -1.81% | |
| Form 8-K DiaMedica Therapeutics For: Feb 20 | SEC filing · Form 8-K | -1.46% | -2.92% | |
| Form 10-Q DiaMedica Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -0.93% | -3.96% | |
| Form 8-K DiaMedica Therapeutics For: Nov 13 | SEC filing · Form 8-K | -0.93% | -3.96% | |
| Form 10-Q DiaMedica Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +2.13% | +2.13% | |
| Form 8-K DiaMedica Therapeutics For: Aug 07 | SEC filing · Form 8-K | +2.13% | +2.13% | |
| Form EFFECT DiaMedica Therapeutics | SEC filing · Form EFFECT | +0.62% | +0.31% | |
| Form S-3 DiaMedica Therapeutics | SEC filing · Form S-3 | +0.00% | +6.31% | |
| Form D DiaMedica Therapeutics | SEC filing · Form D | +0.00% | +2.85% | |
| Form 8-K DiaMedica Therapeutics For: Jun 25 | SEC filing · Form 8-K | -2.33% | +14.73% | |
| Form 8-K DiaMedica Therapeutics For: Jun 26 | SEC filing · Form 8-K | -2.33% | +14.73% | |
| Form S-8 DiaMedica Therapeutics | SEC filing · Form S-8 | -1.75% | -0.35% | |
| Form 8-K DiaMedica Therapeutics For: May 22 | SEC filing · Form 8-K | — | +0.35% | |
| Form 10-Q DiaMedica Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -5.79% | -3.56% | |
| Form 8-K DiaMedica Therapeutics For: May 08 | SEC filing · Form 8-K | -5.79% | -3.56% | |
| Form 8-K DiaMedica Therapeutics For: Apr 05 | SEC filing · Form 8-K | +0.00% | -4.87% | |
| Form EFFECT DiaMedica Therapeutics | SEC filing · Form EFFECT | -1.48% | -1.85% | |
| Form ARS DiaMedica Therapeutics For: Dec 31 | SEC filing · Form ARS | -0.71% | +4.61% | |
| Form DEF 14A DiaMedica Therapeutics For: May 22 | SEC filing · Form DEF | -0.71% | +4.61% | |
| Form DEFA14A DiaMedica Therapeutics | SEC filing · Form DEFA14A | -0.71% | +4.61% | |
| Form S-3 DiaMedica Therapeutics | SEC filing · Form S-3 | -5.24% | +3.00% | |
| Form 10-K DiaMedica Therapeutics For: Dec 31 | SEC filing · Form 10-K | +0.00% | -3.15% | |
| Form 8-K DiaMedica Therapeutics For: Mar 19 | SEC filing · Form 8-K | +0.00% | -3.15% | |
| Form 10-Q DiaMedica Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +6.84% | +17.93% | |
| Form 8-K DiaMedica Therapeutics For: Nov 13 | SEC filing · Form 8-K | +6.84% | +17.93% |
Keep exploring
More DMCAF: earnings → · analyst actions → · DMCAF overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SANTEN PHARM CO UNSP/ADR (SNPHY) | 2 | 0.00% | 0% |
| TODOS MED LTD ORD (TOMDF) | 2 | +8.33% | 50% |
| EUROFINS SCIENTIFIC SA (ERFSF) | 1 | +0.07% | 100% |
| IMRIS INC (IMRSQ) | 1 | 0.00% | 0% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.